EUVIMEDEUVIMED entdecken
Crossref

Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy

Tianling Liao, Qingming Huang, Han Tang, Huadong Xie, Kangji Liao, Zhengwei Su, Chengjie Ban, Zhi Cheng, Xianlin Yi

Genetics and Molecular Research · 2025 · 24 (1)

DOI: 10.4238/z2qb9g57 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, 2025. Verfasst von Tianling Liao und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liao, T., Huang, Q., Tang, H., Xie, H., Liao, K., Su, Z., Ban, C., Cheng, Z., & Yi, X. (2025). Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research, 24(1). https://doi.org/10.4238/z2qb9g57

Vancouver

Liao T, Huang Q, Tang H, Xie H, Liao K, Su Z, et al. Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research. 2025;24(1). doi:10.4238/z2qb9g57

BibTeX
@article{Liao2025,
  author = {Liao, Tianling and Huang, Qingming and Tang, Han and Xie, Huadong and Liao, Kangji and Su, Zhengwei and Ban, Chengjie and Cheng, Zhi and Yi, Xianlin},
  title = {Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy},
  journal = {Genetics and Molecular Research},
  year = {2025},
  volume = {24},
  number = {1},
  doi = {10.4238/z2qb9g57}
}
Kostenlos starten →